Showing results (1-10 of 262) with videos related to
Sort By:
Pageof 27
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 14, 2012
Chapter 7: Description of MISCAN-lung, the Erasmus MC Lung Cancer microsimulation model for evaluating cancer control interventionsF W Schultz, R Boer, H J de KoningCancer|October 20, 1999
A longer breast carcinoma screening interval for women age older than 65 years?R Boer, H J de Koning, P J van der MaasJournal of Medical Screening|August 27, 1998
Radiation risk of mammography related to benefit in screening programmes: a favourable balance?P M Beemsterboer, P G Warmerdam, R Boer, et al.The Journal of Urology|May 1, 1997
A comparison of disease specific survival of patients who died of and who had newly diagnosed prostate cancerR Boer, H J de Koning, P M Beemsterboer, et al.European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
In search of the best upper age limit for breast cancer screeningR Boer, H J de Koning, G J van Oortmarssen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Mammographic screening: evidence from randomised controlled trialsH J de KoningEuropean Journal of Radiology|February 16, 2000
Breast cancer screening; cost-effective in practice?H J De KoningJournal of the National Cancer Institute|August 16, 1995
Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trialsH J de Koning, R Boer, P G Warmerdam, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
How cost-effective is breast cancer screening in different EC countries?B M van Ineveld, G J van Oortmarssen, H J de Koning, et al.BJU International|February 27, 2004
MISCAN: estimating lead-time and over-detection by simulationG Draisma, H J De KoningPageof 27